Fort LP’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $270K | Sell |
257
-31
| -11% | -$32.6K | 0.68% | 61 |
|
|
2024
Q2 | $303K | Buy |
288
+3
| +1% | +$3.15K | 0.77% | 29 |
|
|
2024
Q1 | $274K | Sell |
285
-38
| -12% | -$36.6K | 0.69% | 53 |
|
|
2023
Q4 | $284K | Sell |
323
-25
| -7% | -$22K | 0.7% | 43 |
|
|
2023
Q3 | $286K | Sell |
348
-20
| -5% | -$16.5K | 0.79% | 36 |
|
|
2023
Q2 | $264K | Sell |
368
-49
| -12% | -$35.2K | 0.7% | 76 |
|
|
2023
Q1 | $343K | Sell |
417
-197
| -32% | -$162K | 0.89% | 10 |
|
|
2022
Q4 | $443K | Sell |
614
-101
| -14% | -$72.9K | 0.67% | 39 |
|
|
2022
Q3 | $493K | Sell |
715
-207
| -22% | -$143K | 0.62% | 45 |
|
|
2022
Q2 | $545K | Buy |
922
+47
| +5% | +$27.8K | 0.37% | 144 |
|
|
2022
Q1 | $611K | Buy |
875
+256
| +41% | +$179K | 0.23% | 194 |
|
|
2021
Q4 | $391K | Sell |
619
-488
| -44% | -$308K | 0.13% | 246 |
|
|
2021
Q3 | $670K | Sell |
1,107
-698
| -39% | -$422K | 0.22% | 202 |
|
|
2021
Q2 | $1.01M | Sell |
1,805
-866
| -32% | -$484K | 0.29% | 180 |
|
|
2021
Q1 | $1.26M | Buy |
2,671
+265
| +11% | +$125K | 0.35% | 173 |
|
|
2020
Q4 | $1.16M | Buy |
2,406
+1,325
| +123% | +$640K | 0.35% | 178 |
|
|
2020
Q3 | $605K | Buy |
+1,081
| New | +$605K | 0.25% | 176 |
|